Avai Bio (AVAI) Total Liabilities (2018 - 2023)
Avai Bio's Total Liabilities history spans 5 years, with the latest figure at $1.7 million for Q4 2023.
- For Q4 2023, Total Liabilities rose 105.26% year-over-year to $1.7 million; the TTM value through Dec 2023 reached $1.7 million, up 105.26%, while the annual FY2023 figure was $874719.0, N/A changed from the prior year.
- Total Liabilities for Q4 2023 was $1.7 million at Avai Bio, up from $1.3 million in the prior quarter.
- Across five years, Total Liabilities topped out at $1.7 million in Q4 2023 and bottomed at -$334124.0 in Q4 2020.
- The 4-year median for Total Liabilities is $477932.0 (2020), against an average of $532955.7.
- The largest YoY upside for Total Liabilities was 2915.91% in 2020 against a maximum downside of 300.97% in 2020.
- A 4-year view of Total Liabilities shows it stood at $166259.0 in 2019, then plummeted by 300.97% to -$334124.0 in 2020, then surged by 346.73% to $824372.0 in 2022, then surged by 105.26% to $1.7 million in 2023.
- Per Business Quant, the three most recent readings for AVAI's Total Liabilities are $1.7 million (Q4 2023), $1.3 million (Q3 2023), and $1.3 million (Q2 2023).